NCT01325220 · Interventional trial
Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
Overall registry status Completed
Phase 3
Conditions Fragile X Syndrome
Delaware Valley sites
- Suburban Research Associates/Elwyn Genetics · Media, PA · Delaware County
First posted
Registry updated
Added to the directory